Polynucleotides
Polynucleotides for stretch marks: what does the 20-person trial show?
A small randomised study compared PN injections, fractional laser and their combination for longstanding abdominal stretch marks, with encouraging but preliminary results.
Stretch marks are common scars, not a medical emergency
Stretch marks are narrow lines that develop when skin changes rapidly, including during growth, pregnancy or weight change. They may begin pink, red, purple or brown and often fade to paler lines over time, although they may not disappear. The NHS describes them as common and harmless, so treatment is optional rather than medically necessary.
Large or suddenly developing stretch marks alongside other symptoms may occasionally justify medical assessment, particularly where steroid exposure or an endocrine condition is possible. Consultation should also distinguish established pale stretch marks from newer inflamed marks, because their age, colour, site and the person’s skin type may affect both treatment choice and outcome.
How did the 2025 trial compare treatments?
A prospective randomised intra-individual trial enrolled 20 volunteers with abdominal stretch marks present for more than 12 months. Each person’s affected area was divided into three zones: PN injections alone, fractional carbon-dioxide laser alone and a combination of both. Nineteen participants completed the 20-week study.
Researchers used digital photography, three-dimensional imaging, scar ratings and tissue analysis at several time points. This design allowed three treatments to be compared within the same person, reducing some between-person differences. However, there was no untreated zone, so the study cannot show how measurements would have changed without a procedure or with time alone.
All three zones improved, without a clear winner
Stretch-mark volume and width improved from baseline in the PN, laser and combination zones. The combination produced the largest average numerical reductions, but differences between the three groups were not statistically significant for volume or width. A larger number on a small study chart should not be presented as proof that combination treatment is superior.
PN performed better on the study’s roughness measure and Manchester scar score and caused fewer adverse effects than the laser-containing treatments. Melanin levels increased in the laser and combination zones but remained unchanged in the PN zone. These findings are encouraging, particularly where post-inflammatory pigmentation is a concern, but require confirmation in larger studies.
Why the findings remain preliminary
This was one study with 20 participants, one person did not complete follow-up, and observation ended at 20 weeks. All stretch marks were longstanding and abdominal, so the findings cannot automatically be applied to recent marks, breasts, thighs, arms or other sites. The trial also cannot establish the durability of improvement or an ideal maintenance schedule.
The paper reports that the PN material was supplied by its manufacturer, although the authors declared no competing interests and no specific research funding. Product formulation, injection technique and device settings matter, so results should not be transferred to every PN product or laser. Independent replication and longer follow-up would strengthen confidence.
Downtime and adverse effects differ by method
PN injections may cause stinging, tenderness, redness, swelling, itching, bruising and temporary raised points. Infection and other injection complications are possible even when a small trial reports good tolerability. Laser treatment adds heat-related redness, swelling, crusting and a risk of post-inflammatory pigment change; combining procedures may increase recovery burden without guaranteeing extra benefit.
Increasing pain, spreading redness or heat, discharge, fever, blistering, marked colour change, delayed healing or a persistent lump needs prompt clinical assessment. Treatment over an abdomen recently changed by pregnancy, surgery or substantial weight variation may need to wait. Written aftercare, sun protection where the area is exposed and access to timely review are important.
Suitability and realistic goals come first
Assessment should review when and why the marks developed, their location and colour, pregnancy or breastfeeding, weight stability, medicines including steroid use, medical conditions, allergies, infection, scarring tendency, pigmentation risk and previous procedures. An unusual presentation may need GP or dermatology review before any cosmetic treatment is considered.
Options may include allowing natural fading, camouflage, topical treatment for selected newer marks, microneedling, laser or no intervention. Complete removal should not be promised. GMC guidance requires current evidence, clear explanation of risks and alternatives, and appropriate follow-up; this small trial supports further study of PN for established abdominal stretch marks, not a guaranteed result or standard course for everyone.